These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 18097142)

  • 1. Cerebrospinal fluid/serum IgG index is correlated with medial temporal lobe atrophy in Alzheimer's disease.
    Matsumoto Y; Yanase D; Noguchi-Shinohara M; Ono K; Yoshita M; Yamada M
    Dement Geriatr Cogn Disord; 2008; 25(2):144-7. PubMed ID: 18097142
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Blood-brain barrier permeability correlates with medial temporal lobe atrophy but not with amyloid-beta protein transport across the blood-brain barrier in Alzheimer's disease.
    Matsumoto Y; Yanase D; Noguchi-Shinohara M; Ono K; Yoshita M; Yamada M
    Dement Geriatr Cogn Disord; 2007; 23(4):241-5. PubMed ID: 17310121
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multi-center comparison of medial temporal atrophy in patients with Alzheimer's disease--data from the ICTUS study.
    Galluzzi S; Talassi E; Belussi M; Scheltens P; van de Pol L; Nobili F; Rodriguez G; Froelich L; Damian M; Martinez-Lage P; Gomez-Isla T; Reynish E; Ousset PJ; Vellas B; Frisoni GB
    Dement Geriatr Cogn Disord; 2008; 26(4):314-22. PubMed ID: 18841016
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Medial temporal lobe atrophy in vascular dementia: visual temporal lobe rating scale.
    Cho H; Kwon JH; Seo HJ
    Arch Gerontol Geriatr; 2009; 48(3):415-8. PubMed ID: 18468705
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Behavioural and psychological symptoms are not related to white matter hyperintensities and medial temporal lobe atrophy in Alzheimer's disease.
    Staekenborg SS; Gillissen F; Romkes R; Pijnenburg YA; Barkhof F; Scheltens P; van der Flier WM
    Int J Geriatr Psychiatry; 2008 Apr; 23(4):387-92. PubMed ID: 17907266
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of medial temporal atrophy and white matter hyperintensities on the cognitive functions in patients with Alzheimer's disease.
    Shim YS; Youn YC; Na DL; Kim SY; Cheong HK; Moon SY; Park KW; Ku BD; Lee JY; Jeong JH; Kang H; Kim EJ; Lee JS; Go SM; Kim SH; Cha KR; Seo SW
    Eur Neurol; 2011; 66(2):75-82. PubMed ID: 21778730
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Blood pressure, white matter lesions and medial temporal lobe atrophy: closing the gap between vascular pathology and Alzheimer's disease?
    Korf ES; Scheltens P; Barkhof F; de Leeuw FE
    Dement Geriatr Cogn Disord; 2005; 20(6):331-7. PubMed ID: 16179827
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of white matter hyperintensity on medial temporal lobe atrophy in Alzheimer's disease.
    Jang JW; Kim S; Na HY; Ahn S; Lee SJ; Kwak KH; Lee MA; Hsiung GY; Choi BS; Youn YC
    Eur Neurol; 2013; 69(4):229-35. PubMed ID: 23344183
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cognitive impairment no dementia - neuropsychological and neuroimaging characterization of an amnestic subgroup.
    Jacova C; Peters KR; Beattie BL; Wong E; Riddehough A; Foti D; Scheltens P; Li DK; Feldman HH
    Dement Geriatr Cogn Disord; 2008; 25(3):238-47. PubMed ID: 18264009
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anatomically-distinct genetic associations of APOE epsilon4 allele load with regional cortical atrophy in Alzheimer's disease.
    Filippini N; Rao A; Wetten S; Gibson RA; Borrie M; Guzman D; Kertesz A; Loy-English I; Williams J; Nichols T; Whitcher B; Matthews PM
    Neuroimage; 2009 Feb; 44(3):724-8. PubMed ID: 19013250
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Overtime reliability of medial temporal lobe atrophy rating in a clinical setting.
    Cavallin L; Løken K; Engedal K; Oksengård AR; Wahlund LO; Bronge L; Axelsson R
    Acta Radiol; 2012 Apr; 53(3):318-23. PubMed ID: 22371624
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diabetes mellitus, hypertension and medial temporal lobe atrophy: the LADIS study.
    Korf ES; van Straaten EC; de Leeuw FE; van der Flier WM; Barkhof F; Pantoni L; Basile AM; Inzitari D; Erkinjuntti T; Wahlund LO; Rostrup E; Schmidt R; Fazekas F; Scheltens P;
    Diabet Med; 2007 Feb; 24(2):166-71. PubMed ID: 17257279
    [TBL] [Abstract][Full Text] [Related]  

  • 13. New visual rating system for medial temporal lobe atrophy: a simple diagnostic tool for routine examinations.
    Kaneko T; Kaneko K; Matsushita M; Kadoya M; Ihara N; Ryokawa A; Ogihara T; Inuzuka S; Ueda H
    Psychogeriatrics; 2012 Jun; 12(2):88-92. PubMed ID: 22712641
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of the brain-derived neurotrophic factor and the apolipoprotein E polymorphisms on disease progression in preclinical Alzheimer's disease.
    Hashimoto R; Hirata Y; Asada T; Yamashita F; Nemoto K; Mori T; Moriguchi Y; Kunugi H; Arima K; Ohnishi T
    Genes Brain Behav; 2009 Feb; 8(1):43-52. PubMed ID: 18786162
    [TBL] [Abstract][Full Text] [Related]  

  • 15. History of depression, depressive symptoms, and medial temporal lobe atrophy and the risk of Alzheimer disease.
    Geerlings MI; den Heijer T; Koudstaal PJ; Hofman A; Breteler MM
    Neurology; 2008 Apr; 70(15):1258-64. PubMed ID: 18391157
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Focal atrophy and cerebrovascular disease increase dementia risk among cognitively normal older adults.
    Rosano C; Aizenstein HJ; Wu M; Newman AB; Becker JT; Lopez OL; Kuller LH
    J Neuroimaging; 2007 Apr; 17(2):148-55. PubMed ID: 17441836
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Different atrophic patterns in early- and late-onset Alzheimer's disease and evaluation of clinical utility of a method of regional z-score analysis using voxel-based morphometry.
    Shiino A; Watanabe T; Kitagawa T; Kotani E; Takahashi J; Morikawa S; Akiguchi I
    Dement Geriatr Cogn Disord; 2008; 26(2):175-86. PubMed ID: 18698140
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The anatomical bases of semantic retrieval deficits in early Alzheimer's disease.
    Venneri A; McGeown WJ; Hietanen HM; Guerrini C; Ellis AW; Shanks MF
    Neuropsychologia; 2008 Jan; 46(2):497-510. PubMed ID: 17936858
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of the size and area of the corpus callosum with the Osiris method in Alzheimer's disease.
    Kabay SC; Gulbandilar E; Ozden H; Ozbag D; Guven G; Adapinar B; Durmaz R
    Neurodegener Dis; 2009; 6(4):148-53. PubMed ID: 19521062
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Variations in cortical thickness with dementia severity in Alzheimer's disease.
    Im K; Lee JM; Seo SW; Yoon U; Kim ST; Kim YH; Kim SI; Na DL
    Neurosci Lett; 2008 May; 436(2):227-31. PubMed ID: 18400396
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.